Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death

Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthHealth Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death

Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death.

View Premium plansBrowse free archive reports